PT Kalbe Farma Tbk (KLBF) mengalokasikan belanja modal atau capital expenditure (capex) sebesar Rp1 triliun pada 2024.
Dana tersebut untuk penambahan kapasitas dan pemeliharaan di sejumlah fasilitas milik perseroan.
Dana tersebut untuk penambahan kapasitas dan pemeliharaan di sejumlah fasilitas milik perseroan.
Category
📺
TVTranscript
00:00 The PT KLB Pharma Tbk allocated capital expenditure of Rp1 trillion in 2024.
00:08 There are also Capex funds from internal cash flow.
00:12 Until the first quarter of 2024, the realization of Capex per share is still below Rp200 billion.
00:22 The PT KLB Pharma Tbk allocated capital expenditure of Rp1 trillion in 2024.
00:30 The funds are for additional capacity and maintenance in some facilities owned by the shareholders.
00:36 In the official statement, the company management explained that the Capex funds are from the internal cash flow of the shareholders in good condition.
00:43 Until the first quarter of 2024, the realization of Capex per share is still below Rp200 billion.
00:50 As reported in February, KLBF through the PT Global Owned Kaleb Pharma
00:55 is in the process of building a facility for the production of radioisotope and radiopharmacology,
01:00 especially fluorodeoxyglucose or FGD for the need to detect cancer diseases.
01:07 The radiopharmacology production facility that produces fluorodeoxyglucose or FGD
01:13 is very needed to support the inspection service of the tomography and computer tomography scanning position at the hospital.
01:22 Reported by IDX Channel.
01:24 [Music]
01:28 [Music]
01:31 [BLANK_AUDIO]